Back to Search

MELISSA RUBENSTEIN, MD

MD

Dermatology Physician

NPI: 1164587671IndividualAccepts Medicare

Specialties, Licenses & Credentials

Dermatology PhysicianPrimary

Dermatology

Code: 207N00000X

M5473(TX)

CMS Specialties

PrimaryDERMATOLOGY

Education

BAYLOR COLLEGE OF MEDICINE

Class of 2004

Research & Publications (20)

Treatment of prostate and breast tumors employing mono- and bi-specific antisense oligonucleotides targeting apoptosis inhibitory proteins clusterin and bcl-2.
PMID 19533419·Med Oncol·2010
8-other
Regenerative patterning in Swarm Robots: mutual benefits of research in robotics and stem cell biology.
PMID 19557691·Int J Dev Biol·2009
7-preclinical
Multigene targeting of signal transduction pathways for the treatment of breast and prostate tumors: comparison between combination therapies employing bispecific oligonucleotides with either Rapamycin or Paclitaxel.
PMID 18686047·Med Oncol·2009
4-observational
Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease.
PMID 17879274·Inflamm Bowel Dis·2008
8-other
Do intra-tumor alkaline micro-regions represent additional therapeutically privileged sites?
PMID 18364249·Med Hypotheses·2008
7-preclinical
Treatment of MCF-7 breast cancer cells employing mono- and bispecific antisense oligonucleotides having binding specificity toward proteins associated with autocrine regulated growth and BCL-2.
PMID 17972023·Med Oncol·2008
8-other
Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors.
PMID 17848743·Med Oncol·2007
4-observational
Combination chemotherapy employing bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors.
PMID 17917084·Med Oncol·2007
8-other
Targeting of biotinylated oligonucleotides to prostate tumors with antibody-based delivery vehicles.
PMID 17541843·J Drug Target·2007
7-preclinical
Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus.
PMID 17402372·Lupus·2007
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
17051 DALLAS PKWY STE 350
ADDISON, TX 75001

Quick Facts

NPI
1164587671
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
22
Publications
20

Are you this provider?

Claim Your Profile